nodes	percent_of_prediction	percent_of_DWPC	metapath
Butorphanol—Blood pressure increased—Sorafenib—liver cancer	0.0231	0.0231	CcSEcCtD
Butorphanol—Pain in extremity—Sorafenib—liver cancer	0.0168	0.0168	CcSEcCtD
Butorphanol—Hypotonia—Epirubicin—liver cancer	0.0162	0.0162	CcSEcCtD
Butorphanol—Abdominal pain upper—Sorafenib—liver cancer	0.0153	0.0153	CcSEcCtD
Butorphanol—Hypotonia—Doxorubicin—liver cancer	0.015	0.015	CcSEcCtD
Butorphanol—Dysphagia—Sorafenib—liver cancer	0.0145	0.0145	CcSEcCtD
Butorphanol—Epistaxis—Sorafenib—liver cancer	0.0122	0.0122	CcSEcCtD
Butorphanol—Hyperaesthesia—Epirubicin—liver cancer	0.0109	0.0109	CcSEcCtD
Butorphanol—Feeling hot—Epirubicin—liver cancer	0.0109	0.0109	CcSEcCtD
Butorphanol—Tinnitus—Sorafenib—liver cancer	0.0108	0.0108	CcSEcCtD
Butorphanol—Ageusia—Epirubicin—liver cancer	0.0105	0.0105	CcSEcCtD
Butorphanol—Petechiae—Epirubicin—liver cancer	0.0104	0.0104	CcSEcCtD
Butorphanol—Arrhythmia—Sorafenib—liver cancer	0.0104	0.0104	CcSEcCtD
Butorphanol—Erythema—Sorafenib—liver cancer	0.0101	0.0101	CcSEcCtD
Butorphanol—Hyperaesthesia—Doxorubicin—liver cancer	0.0101	0.0101	CcSEcCtD
Butorphanol—Feeling hot—Doxorubicin—liver cancer	0.0101	0.0101	CcSEcCtD
Butorphanol—Ageusia—Doxorubicin—liver cancer	0.00975	0.00975	CcSEcCtD
Butorphanol—Vasodilation—Epirubicin—liver cancer	0.00971	0.00971	CcSEcCtD
Butorphanol—Vasodilation procedure—Epirubicin—liver cancer	0.00971	0.00971	CcSEcCtD
Butorphanol—Muscle spasms—Sorafenib—liver cancer	0.00971	0.00971	CcSEcCtD
Butorphanol—Petechiae—Doxorubicin—liver cancer	0.0096	0.0096	CcSEcCtD
Butorphanol—Thinking abnormal—Epirubicin—liver cancer	0.00932	0.00932	CcSEcCtD
Butorphanol—Dyskinesia—Epirubicin—liver cancer	0.00908	0.00908	CcSEcCtD
Butorphanol—Syncope—Sorafenib—liver cancer	0.00905	0.00905	CcSEcCtD
Butorphanol—Dysarthria—Epirubicin—liver cancer	0.00902	0.00902	CcSEcCtD
Butorphanol—Vasodilation—Doxorubicin—liver cancer	0.00899	0.00899	CcSEcCtD
Butorphanol—Vasodilation procedure—Doxorubicin—liver cancer	0.00899	0.00899	CcSEcCtD
Butorphanol—Loss of consciousness—Sorafenib—liver cancer	0.00887	0.00887	CcSEcCtD
Butorphanol—Cough—Sorafenib—liver cancer	0.00881	0.00881	CcSEcCtD
Butorphanol—Gait disturbance—Epirubicin—liver cancer	0.00875	0.00875	CcSEcCtD
Butorphanol—Hypertension—Sorafenib—liver cancer	0.00872	0.00872	CcSEcCtD
Butorphanol—Coordination abnormal—Epirubicin—liver cancer	0.00869	0.00869	CcSEcCtD
Butorphanol—Thinking abnormal—Doxorubicin—liver cancer	0.00863	0.00863	CcSEcCtD
Butorphanol—Abnormal dreams—Epirubicin—liver cancer	0.00844	0.00844	CcSEcCtD
Butorphanol—Dry mouth—Sorafenib—liver cancer	0.00841	0.00841	CcSEcCtD
Butorphanol—Dyskinesia—Doxorubicin—liver cancer	0.0084	0.0084	CcSEcCtD
Butorphanol—Dysarthria—Doxorubicin—liver cancer	0.00835	0.00835	CcSEcCtD
Butorphanol—Shock—Sorafenib—liver cancer	0.00811	0.00811	CcSEcCtD
Butorphanol—Gait disturbance—Doxorubicin—liver cancer	0.00809	0.00809	CcSEcCtD
Butorphanol—Coordination abnormal—Doxorubicin—liver cancer	0.00804	0.00804	CcSEcCtD
Butorphanol—Anorexia—Sorafenib—liver cancer	0.00785	0.00785	CcSEcCtD
Butorphanol—Abnormal dreams—Doxorubicin—liver cancer	0.00781	0.00781	CcSEcCtD
Butorphanol—Mental disability—Epirubicin—liver cancer	0.00741	0.00741	CcSEcCtD
Butorphanol—Dyspnoea—Sorafenib—liver cancer	0.00735	0.00735	CcSEcCtD
Butorphanol—Decreased appetite—Sorafenib—liver cancer	0.00716	0.00716	CcSEcCtD
Butorphanol—Constipation—Sorafenib—liver cancer	0.00705	0.00705	CcSEcCtD
Butorphanol—Eye pain—Epirubicin—liver cancer	0.00686	0.00686	CcSEcCtD
Butorphanol—Mental disability—Doxorubicin—liver cancer	0.00685	0.00685	CcSEcCtD
Butorphanol—Gastrointestinal pain—Sorafenib—liver cancer	0.00674	0.00674	CcSEcCtD
Butorphanol—Increased appetite—Epirubicin—liver cancer	0.0066	0.0066	CcSEcCtD
Butorphanol—Urticaria—Sorafenib—liver cancer	0.00655	0.00655	CcSEcCtD
Butorphanol—Abdominal pain—Sorafenib—liver cancer	0.00651	0.00651	CcSEcCtD
Butorphanol—Body temperature increased—Sorafenib—liver cancer	0.00651	0.00651	CcSEcCtD
Butorphanol—Eye pain—Doxorubicin—liver cancer	0.00635	0.00635	CcSEcCtD
Butorphanol—Lethargy—Epirubicin—liver cancer	0.00632	0.00632	CcSEcCtD
Butorphanol—Osteoarthritis—Epirubicin—liver cancer	0.0062	0.0062	CcSEcCtD
Butorphanol—Diplopia—Epirubicin—liver cancer	0.0062	0.0062	CcSEcCtD
Butorphanol—Pain in extremity—Epirubicin—liver cancer	0.0062	0.0062	CcSEcCtD
Butorphanol—Increased appetite—Doxorubicin—liver cancer	0.0061	0.0061	CcSEcCtD
Butorphanol—Asthenia—Sorafenib—liver cancer	0.00591	0.00591	CcSEcCtD
Butorphanol—Lethargy—Doxorubicin—liver cancer	0.00585	0.00585	CcSEcCtD
Butorphanol—Pruritus—Sorafenib—liver cancer	0.00583	0.00583	CcSEcCtD
Butorphanol—Ataxia—Epirubicin—liver cancer	0.00583	0.00583	CcSEcCtD
Butorphanol—Pain in extremity—Doxorubicin—liver cancer	0.00573	0.00573	CcSEcCtD
Butorphanol—Diplopia—Doxorubicin—liver cancer	0.00573	0.00573	CcSEcCtD
Butorphanol—Osteoarthritis—Doxorubicin—liver cancer	0.00573	0.00573	CcSEcCtD
Butorphanol—Abdominal pain upper—Epirubicin—liver cancer	0.00566	0.00566	CcSEcCtD
Butorphanol—Dizziness—Sorafenib—liver cancer	0.00545	0.00545	CcSEcCtD
Butorphanol—Ataxia—Doxorubicin—liver cancer	0.00539	0.00539	CcSEcCtD
Butorphanol—Dysphagia—Epirubicin—liver cancer	0.00536	0.00536	CcSEcCtD
Butorphanol—Vomiting—Sorafenib—liver cancer	0.00524	0.00524	CcSEcCtD
Butorphanol—Abdominal pain upper—Doxorubicin—liver cancer	0.00524	0.00524	CcSEcCtD
Butorphanol—Rash—Sorafenib—liver cancer	0.0052	0.0052	CcSEcCtD
Butorphanol—Dermatitis—Sorafenib—liver cancer	0.00519	0.00519	CcSEcCtD
Butorphanol—Headache—Sorafenib—liver cancer	0.00516	0.00516	CcSEcCtD
Butorphanol—Bronchitis—Epirubicin—liver cancer	0.00515	0.00515	CcSEcCtD
Butorphanol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00498	0.00498	CcSEcCtD
Butorphanol—Dysphagia—Doxorubicin—liver cancer	0.00496	0.00496	CcSEcCtD
Butorphanol—Nausea—Sorafenib—liver cancer	0.00489	0.00489	CcSEcCtD
Butorphanol—Drowsiness—Epirubicin—liver cancer	0.00478	0.00478	CcSEcCtD
Butorphanol—Bronchitis—Doxorubicin—liver cancer	0.00477	0.00477	CcSEcCtD
Butorphanol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00461	0.00461	CcSEcCtD
Butorphanol—Sweating—Epirubicin—liver cancer	0.00458	0.00458	CcSEcCtD
Butorphanol—Epistaxis—Epirubicin—liver cancer	0.0045	0.0045	CcSEcCtD
Butorphanol—Sinusitis—Epirubicin—liver cancer	0.00448	0.00448	CcSEcCtD
Butorphanol—Drowsiness—Doxorubicin—liver cancer	0.00442	0.00442	CcSEcCtD
Butorphanol—Rhinitis—Epirubicin—liver cancer	0.0043	0.0043	CcSEcCtD
Butorphanol—Pharyngitis—Epirubicin—liver cancer	0.00425	0.00425	CcSEcCtD
Butorphanol—Sweating—Doxorubicin—liver cancer	0.00424	0.00424	CcSEcCtD
Butorphanol—Epistaxis—Doxorubicin—liver cancer	0.00417	0.00417	CcSEcCtD
Butorphanol—Sinusitis—Doxorubicin—liver cancer	0.00415	0.00415	CcSEcCtD
Butorphanol—Visual impairment—Epirubicin—liver cancer	0.00413	0.00413	CcSEcCtD
Butorphanol—Eye disorder—Epirubicin—liver cancer	0.00401	0.00401	CcSEcCtD
Butorphanol—Tinnitus—Epirubicin—liver cancer	0.004	0.004	CcSEcCtD
Butorphanol—Rhinitis—Doxorubicin—liver cancer	0.00398	0.00398	CcSEcCtD
Butorphanol—Pharyngitis—Doxorubicin—liver cancer	0.00394	0.00394	CcSEcCtD
Butorphanol—Chills—Epirubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Butorphanol—Arrhythmia—Epirubicin—liver cancer	0.00383	0.00383	CcSEcCtD
Butorphanol—Visual impairment—Doxorubicin—liver cancer	0.00382	0.00382	CcSEcCtD
Butorphanol—Erythema—Epirubicin—liver cancer	0.00373	0.00373	CcSEcCtD
Butorphanol—Eye disorder—Doxorubicin—liver cancer	0.00371	0.00371	CcSEcCtD
Butorphanol—Tinnitus—Doxorubicin—liver cancer	0.0037	0.0037	CcSEcCtD
Butorphanol—Flatulence—Epirubicin—liver cancer	0.00368	0.00368	CcSEcCtD
Butorphanol—Tension—Epirubicin—liver cancer	0.00366	0.00366	CcSEcCtD
Butorphanol—Nervousness—Epirubicin—liver cancer	0.00362	0.00362	CcSEcCtD
Butorphanol—Back pain—Epirubicin—liver cancer	0.00361	0.00361	CcSEcCtD
Butorphanol—Muscle spasms—Epirubicin—liver cancer	0.00359	0.00359	CcSEcCtD
Butorphanol—Chills—Doxorubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Butorphanol—Arrhythmia—Doxorubicin—liver cancer	0.00354	0.00354	CcSEcCtD
Butorphanol—Vision blurred—Epirubicin—liver cancer	0.00352	0.00352	CcSEcCtD
Butorphanol—Erythema—Doxorubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Butorphanol—Agitation—Epirubicin—liver cancer	0.00343	0.00343	CcSEcCtD
Butorphanol—Flatulence—Doxorubicin—liver cancer	0.0034	0.0034	CcSEcCtD
Butorphanol—Tension—Doxorubicin—liver cancer	0.00339	0.00339	CcSEcCtD
Butorphanol—Nervousness—Doxorubicin—liver cancer	0.00335	0.00335	CcSEcCtD
Butorphanol—Vertigo—Epirubicin—liver cancer	0.00335	0.00335	CcSEcCtD
Butorphanol—Syncope—Epirubicin—liver cancer	0.00335	0.00335	CcSEcCtD
Butorphanol—Back pain—Doxorubicin—liver cancer	0.00334	0.00334	CcSEcCtD
Butorphanol—Muscle spasms—Doxorubicin—liver cancer	0.00332	0.00332	CcSEcCtD
Butorphanol—Palpitations—Epirubicin—liver cancer	0.0033	0.0033	CcSEcCtD
Butorphanol—Loss of consciousness—Epirubicin—liver cancer	0.00328	0.00328	CcSEcCtD
Butorphanol—Cough—Epirubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Butorphanol—Vision blurred—Doxorubicin—liver cancer	0.00325	0.00325	CcSEcCtD
Butorphanol—Convulsion—Epirubicin—liver cancer	0.00323	0.00323	CcSEcCtD
Butorphanol—Hypertension—Epirubicin—liver cancer	0.00322	0.00322	CcSEcCtD
Butorphanol—Chest pain—Epirubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Butorphanol—Agitation—Doxorubicin—liver cancer	0.00317	0.00317	CcSEcCtD
Butorphanol—Anxiety—Epirubicin—liver cancer	0.00317	0.00317	CcSEcCtD
Butorphanol—Dry mouth—Epirubicin—liver cancer	0.00311	0.00311	CcSEcCtD
Butorphanol—Vertigo—Doxorubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Butorphanol—Syncope—Doxorubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Butorphanol—Confusional state—Epirubicin—liver cancer	0.00307	0.00307	CcSEcCtD
Butorphanol—Palpitations—Doxorubicin—liver cancer	0.00305	0.00305	CcSEcCtD
Butorphanol—Oedema—Epirubicin—liver cancer	0.00305	0.00305	CcSEcCtD
Butorphanol—Loss of consciousness—Doxorubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Butorphanol—Cough—Doxorubicin—liver cancer	0.00301	0.00301	CcSEcCtD
Butorphanol—Shock—Epirubicin—liver cancer	0.003	0.003	CcSEcCtD
Butorphanol—Convulsion—Doxorubicin—liver cancer	0.00299	0.00299	CcSEcCtD
Butorphanol—Hypertension—Doxorubicin—liver cancer	0.00298	0.00298	CcSEcCtD
Butorphanol—Tachycardia—Epirubicin—liver cancer	0.00297	0.00297	CcSEcCtD
Butorphanol—Hyperhidrosis—Epirubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Butorphanol—Chest pain—Doxorubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Butorphanol—Anxiety—Doxorubicin—liver cancer	0.00293	0.00293	CcSEcCtD
Butorphanol—Anorexia—Epirubicin—liver cancer	0.0029	0.0029	CcSEcCtD
Butorphanol—Dry mouth—Doxorubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Butorphanol—Hypotension—Epirubicin—liver cancer	0.00285	0.00285	CcSEcCtD
Butorphanol—Confusional state—Doxorubicin—liver cancer	0.00284	0.00284	CcSEcCtD
Butorphanol—Oedema—Doxorubicin—liver cancer	0.00282	0.00282	CcSEcCtD
Butorphanol—Shock—Doxorubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Butorphanol—Insomnia—Epirubicin—liver cancer	0.00275	0.00275	CcSEcCtD
Butorphanol—Tachycardia—Doxorubicin—liver cancer	0.00275	0.00275	CcSEcCtD
Butorphanol—Paraesthesia—Epirubicin—liver cancer	0.00273	0.00273	CcSEcCtD
Butorphanol—Hyperhidrosis—Doxorubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Butorphanol—Dyspnoea—Epirubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Butorphanol—Somnolence—Epirubicin—liver cancer	0.00271	0.00271	CcSEcCtD
Butorphanol—Anorexia—Doxorubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Butorphanol—Decreased appetite—Epirubicin—liver cancer	0.00265	0.00265	CcSEcCtD
Butorphanol—Hypotension—Doxorubicin—liver cancer	0.00263	0.00263	CcSEcCtD
Butorphanol—Constipation—Epirubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Butorphanol—Insomnia—Doxorubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Butorphanol—Paraesthesia—Doxorubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Butorphanol—Dyspnoea—Doxorubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Butorphanol—Feeling abnormal—Epirubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Butorphanol—Somnolence—Doxorubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Butorphanol—Gastrointestinal pain—Epirubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Butorphanol—Decreased appetite—Doxorubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Butorphanol—Urticaria—Epirubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Butorphanol—Constipation—Doxorubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Butorphanol—Abdominal pain—Epirubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Butorphanol—Body temperature increased—Epirubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Butorphanol—Feeling abnormal—Doxorubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Butorphanol—Gastrointestinal pain—Doxorubicin—liver cancer	0.0023	0.0023	CcSEcCtD
Butorphanol—Urticaria—Doxorubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Butorphanol—Body temperature increased—Doxorubicin—liver cancer	0.00223	0.00223	CcSEcCtD
Butorphanol—Abdominal pain—Doxorubicin—liver cancer	0.00223	0.00223	CcSEcCtD
Butorphanol—Asthenia—Epirubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Butorphanol—Pruritus—Epirubicin—liver cancer	0.00215	0.00215	CcSEcCtD
Butorphanol—Asthenia—Doxorubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Butorphanol—Dizziness—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Butorphanol—Pruritus—Doxorubicin—liver cancer	0.00199	0.00199	CcSEcCtD
Butorphanol—Vomiting—Epirubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Butorphanol—Rash—Epirubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Butorphanol—Dermatitis—Epirubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Butorphanol—Headache—Epirubicin—liver cancer	0.00191	0.00191	CcSEcCtD
Butorphanol—Dizziness—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Butorphanol—Nausea—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Butorphanol—Vomiting—Doxorubicin—liver cancer	0.00179	0.00179	CcSEcCtD
Butorphanol—Rash—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Butorphanol—Dermatitis—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Butorphanol—Headache—Doxorubicin—liver cancer	0.00177	0.00177	CcSEcCtD
Butorphanol—Nausea—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
